Evidence map›Paper›PMID 20616742›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2010

The early interferon alpha subtype response in infant macaques infected orally with SIV.

Juliet Easlick, Richard Szubin, Samantha Lantz, Nicole Baumgarth, Kristina Abel

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Cecropin anisaxin-2S hasFrontiers in immunology · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2013
    Article
  15. Article
  16. High-throughput quantitative real-time polymerase chain reaction array for absolute and relative quantification of rhesus macaque types I, II, and III interferon and their subtypes.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Juliet EaslickDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Richard Szubin
Samantha Lantz
Nicole Baumgarth
Kristina Abel
University of California, Davis · USFlorida State University · USUniversity of Alabama at Birmingham · USUniversity of North Carolina at Chapel Hill · US

Funding

ZONA PELLUCIDA PEPTIDES AS IMMUNOCONTRACEPTIVE ANTIGENSP51RR000169 · NCRR · UNIVERSITY OF CALIFORNIA DAVIS · PI HYDE, DALLAS MELVIN · 1985 to 2011
$126.2M
The Oral Mucosa in HIV Disease: Innate ImmunityP01DE016839 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGABIAN, NINA · 2005 to 2007
$2.6M
Role of type I interferons in mucosal anti-SIV immunityR21DE016541 · NIDCR · UNIVERSITY OF CALIFORNIA DAVIS · PI ABEL, KRISTINA · 2004 to 2005
$413k
NCRR NIH HHS P51 RR000169NCRR NIH HHS P51 RR00169-41NIDCR NIH HHS 1P01 DE016839NIDCR NIH HHS 1R21DE016541NIDCR NIH HHS P01 DE016839NIDCR NIH HHS R21 DE016541
6 · The paper itself

Abstract

Type I interferons play an important role in the early defense against viral and other pathogens. These innate responses are also critically important in shaping the subsequent adaptive response. Thus, a more thorough knowledge of innate response types and mechanisms will improve our understanding of pathogenesis and guide the development of new therapeutics. Interferon alpha (IFN-alpha) is used clinically in the treatment of HIV and hepatitis C infections. The majority of IFA-alpha therapy is based on a single IFN-alpha subtype, IFN-alpha2. However, IFN-alpha comprises a family of multiple subtypes. The biologic functions of the distinct subtypes and how they relate to disease are poorly understood. The current study developed the tools to distinguish and measure multiple IFN-alpha subtypes on the mRNA level in rhesus macaques that are used widely as an important animal model for human diseases. We were able to identify and measure nine distinct rhesus IFN-alpha subtypes. Furthermore, we could demonstrate that in response to oral pathogenic SIV infection, several IFN-alpha subtypes are rapidly induced in lymphoid but not at oral and gastrointestinal mucosal surfaces. Although each IFN-alpha subtype was induced at distinct levels, their relative expression patterns were identical in all lymphoid tissues examined.

Indexed as

AnimalsAnimals, NewbornGene Expression ProfilingInterferon-alphaIntestinal MucosaLymphoid TissueMacaca mulattaMouth MucosaRNA, MessengerSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusInterferon-alphaRNA, Messenger

Identifiers

PMID20616742
PMCPMC2927738
OpenAlexW2075090863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.